Fischer David B 4
4 · BALCHEM CORP · Filed Feb 13, 2026
Research Summary
AI-generated summary of this filing
BALCHEM Director David B. Fischer Receives 870-Share Award
What Happened David B. Fischer, a director of BALCHEM CORP (BCPC), was granted 870 restricted shares on February 11, 2026. The shares were reported as acquired at $0.00 per share (total reported acquisition value $0). This transaction is an award/grant (code A) rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-02-11; filing date: 2026-02-13 (timely filing).
- Price: $0.00 per share; 870 shares acquired; reported acquisition value $0.
- Shares owned after transaction: not specified in the provided filing summary.
- Footnote: award vests one year after the grant date and is subject to transfer restrictions under the Restricted Stock Grant Agreement.
- Transaction type: Award/Grant (code A) — not a sale or exercised option.
Context Restricted stock grants are commonly used for compensation and retention; they do not represent a market purchase and may be forfeited if vesting conditions are not met. Such awards are routine for insiders and do not by themselves indicate a buying or selling signal.
Insider Transaction Report
Form 4
BALCHEM CORPBCPC
Fischer David B
Director
Transactions
- Award
Common Stock
[F1]2026-02-11+870→ 8,859 total
Footnotes (1)
- [F1]Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
Signature
/s/ Travis Larsen, Attorney in Fact for David B Fischer|2026-02-13